Get the Stockscreener App
2.88
0.69%
-0.02
Cardiff Oncology Inc Stock (CRDF) Forecast
The Cardiff Oncology Inc (CRDF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.71, representing a +445.55% increase from the current price of $2.88. The highest analyst price target is $18.33, and the lowest is $13.10.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CRDF Price Target
Average 13.48
(+368.05% Upside)
Is Cardiff Oncology Inc (CRDF) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.85 | Neutral |
| STOCH(9,6) | 67.16 | Neutral |
| STOCHRSI(14) | 82.00 | Sell |
| MACD(12,26) | -0.177 | Buy |
| ADX(14) | 21.93 | Neutral |
| William %R | -43.48 | Neutral |
| CCI(14) | 21.75 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.845
Buy
|
2.8769
Buy
|
| MA20 |
2.84
Buy
|
2.9754
Sell
|
| MA50 |
3.5619
Sell
|
3.3131
Sell
|
| MA100 |
3.6752
Sell
|
3.414
Sell
|
| MA200 |
3.1292
Sell
|
3.3359
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, CRDF could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 8 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on CRDF, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.85 indicates that CRDF is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 67.16 indicates that CRDF is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 82 indicates that CRDF is oversold. This suggests that CRDF price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.93 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 21.75 indicates that CRDF is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CRDF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cardiff Oncology Inc financial reports and earnings history, Cardiff Oncology Inc (CRDF) stock could reach $29.23 by 2030, $22.76 by 2040 and $31.34 by 2050. See the projected annual prices until 2050 of the Cardiff Oncology Inc stock below:
- Cardiff Oncology Inc (CRDF) is expected to reach an average price of $19.23 in 2035, with a high prediction of $20.67 and a low estimate of $18.51. This indicates an $567.60% rise from the last recorded price of $2.88.
- Cardiff Oncology Inc (CRDF) stock is projected to chart a bullish course in 2040, with an average price target of $20.65, representing an $617.05% surge from its current level. The forecast ranges from a conservative $20.56 to a sky-high $22.76.
- Our analysts predict Cardiff Oncology Inc (CRDF) to jump 808.03% by 2045, soaring from $25.83 to an average price of $26.15, potentially reaching $27.00. While $25.83 is the low estimate, the potential upside is significant.
- Cardiff Oncology Inc (CRDF) stock is expected to climb by 2050, reaching an average of $31.11, a $980.30% jump from its current level. However, a wide range of estimates exists, with high and low targets of $31.34 and $29.76, respectively, highlighting the market's uncertainty.
Cardiff Oncology Inc Stock (CRDF) Year by Year Forecast
Cardiff Oncology Inc Stock (CRDF) Price Forecast for 2025
Cardiff Oncology Inc Stock (CRDF) is expected to reach an average price of $18.66 in 2025, with a high prediction of $28.70 and a low estimate of $8.633. This indicates an +548.08% rise from the last recorded price of $2.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $16.38 | $13.10 | $18.33 | +468.64% |
| June, 2025 | $14.26 | $11.51 | $16.60 | +395.04% |
| July, 2025 | $12.75 | $12.38 | $15.45 | +342.79% |
| August, 2025 | $13.03 | $11.48 | $13.78 | +352.51% |
| September, 2025 | $11.18 | $10.85 | $13.28 | +288.28% |
| October, 2025 | $10.19 | $9.8677 | $12.17 | +253.74% |
| November, 2025 | $9.0578 | $8.7978 | $10.62 | +214.51% |
| December, 2025 | $11.14 | $8.633 | $11.58 | +286.91% |
Cardiff Oncology Inc Stock (CRDF) Price Forecast for 2026
The predicted value for Cardiff Oncology Inc (CRDF) in 2026 is set at an average of $8.9988. Estimates vary from a peak of $12.42 to a trough of $5.5745, indicating an +212.46% surge from the present price of $2.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $11.23 | $10.08 | $12.42 | +290.04% |
| February, 2026 | $10.35 | $10.30 | $11.44 | +259.49% |
| March, 2026 | $9.5134 | $9.4934 | $10.37 | +230.33% |
| April, 2026 | $9.6886 | $9.0835 | $10.35 | +236.41% |
| May, 2026 | $10.47 | $9.3437 | $10.70 | +263.50% |
| June, 2026 | $7.5689 | $7.1989 | $11.46 | +162.81% |
| July, 2026 | $6.9541 | $6.759 | $7.9814 | +141.46% |
| August, 2026 | $6.8542 | $6.3942 | $7.1291 | +137.99% |
| September, 2026 | $5.8994 | $5.8595 | $7.1393 | +104.84% |
| October, 2026 | $5.7395 | $5.5745 | $5.9844 | +99.29% |
| November, 2026 | $6.6597 | $5.6246 | $6.9397 | +131.24% |
| December, 2026 | $7.7549 | $6.0647 | $8.0049 | +169.27% |
Cardiff Oncology Inc Stock (CRDF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cardiff Oncology Inc (CRDF) is $7.1004, with a high forecast of $8.0702 and a low forecast of $6.1306. This indicates an +146.54% increase from the last price of $2.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.185 | $6.5451 | $7.7349 | +149.48% |
| February, 2027 | $7.4051 | $7.0851 | $7.7764 | +157.12% |
| March, 2027 | $6.3303 | $6.2753 | $8.0702 | +119.80% |
| April, 2027 | $6.4104 | $6.2104 | $6.5004 | +122.59% |
| May, 2027 | $6.2106 | $6.1456 | $6.5305 | +115.65% |
| June, 2027 | $6.3058 | $6.1306 | $6.5807 | +118.95% |
| July, 2027 | $6.5759 | $6.2008 | $6.6858 | +128.33% |
| August, 2027 | $7.036 | $6.5985 | $7.146 | +144.31% |
| September, 2027 | $6.9412 | $6.7512 | $7.2511 | +141.01% |
| October, 2027 | $6.8914 | $6.681 | $7.3063 | +139.28% |
| November, 2027 | $7.0415 | $6.6565 | $7.1415 | +144.50% |
| December, 2027 | $6.9867 | $6.9416 | $7.3165 | +142.59% |
Cardiff Oncology Inc Stock (CRDF) Price Forecast for 2028
In 2028, Cardiff Oncology Inc (CRDF) is projected to reach an average price of $9.6182, with a high projection of $12.55 and a low estimate of $6.688. This indicates an +233.97% rise from the last price of $2.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.9068 | $6.8668 | $7.2868 | +139.82% |
| February, 2028 | $6.997 | $6.8269 | $7.0919 | +142.95% |
| March, 2028 | $7.4121 | $6.922 | $8.3471 | +157.37% |
| April, 2028 | $7.4723 | $7.2923 | $7.5167 | +159.45% |
| May, 2028 | $6.8175 | $6.7975 | $7.6824 | +136.72% |
| June, 2028 | $6.8776 | $6.688 | $6.9725 | +138.81% |
| July, 2028 | $7.0577 | $6.7226 | $7.1077 | +145.06% |
| August, 2028 | $7.3829 | $7.0529 | $7.4529 | +156.35% |
| September, 2028 | $7.4531 | $7.3779 | $7.733 | +158.79% |
| October, 2028 | $7.7532 | $7.4482 | $7.9082 | +169.21% |
| November, 2028 | $11.13 | $7.6882 | $12.16 | +286.40% |
| December, 2028 | $11.77 | $10.31 | $12.55 | +308.63% |
Cardiff Oncology Inc Stock (CRDF) Price Forecast for 2029
The 2029 price forecast for Cardiff Oncology Inc Stock (CRDF) is $19.05 on average, with a high prediction of $31.89 and a low estimate of $6.2008. This represents an +561.35% increase from the previous price of $2.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.75 | $6.65 | $11.83 | +134.38% |
| February, 2029 | $6.4903 | $6.3401 | $6.9101 | +125.36% |
| March, 2029 | $6.5206 | $6.4006 | $6.6305 | +126.41% |
| April, 2029 | $7.3008 | $6.2008 | $7.3908 | +153.50% |
| May, 2029 | $8.7412 | $7.1109 | $9.4111 | +203.51% |
| June, 2029 | $10.39 | $8.6613 | $11.36 | +260.82% |
| July, 2029 | $11.90 | $9.8316 | $12.64 | +313.26% |
| August, 2029 | $12.03 | $10.44 | $14.20 | +317.78% |
| September, 2029 | $20.25 | $11.47 | $22.06 | +603.21% |
| October, 2029 | $22.03 | $18.20 | $24.27 | +665.03% |
| November, 2029 | $28.25 | $21.30 | $29.01 | +881.01% |
| December, 2029 | $27.97 | $24.35 | $31.89 | +871.30% |
Cardiff Oncology Inc Stock (CRDF) Price Forecast for 2030
Cardiff Oncology Inc Stock (CRDF) is expected to reach an average price of $20.81 in 2030, with a high forecast of $29.23 and a low forecast of $12.39. This signifies an +622.56% surge from the last price of $2.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $17.50 | $16.81 | $29.23 | +507.77% |
| February, 2030 | $18.39 | $16.41 | $21.67 | +538.68% |
| March, 2030 | $18.33 | $14.90 | $18.87 | +536.60% |
| April, 2030 | $16.23 | $15.84 | $18.74 | +463.70% |
| May, 2030 | $15.66 | $14.99 | $17.32 | +443.92% |
| June, 2030 | $15.12 | $14.43 | $16.06 | +424.83% |
| July, 2030 | $13.94 | $13.55 | $15.66 | +383.87% |
| August, 2030 | $13.27 | $12.39 | $14.33 | +360.62% |
| September, 2030 | $14.96 | $12.86 | $15.40 | +419.31% |
| October, 2030 | $14.47 | $13.93 | $16.27 | +402.31% |
| November, 2030 | $13.96 | $13.81 | $15.08 | +384.61% |
| December, 2030 | $13.70 | $13.17 | $14.31 | +375.59% |
0.24%
36.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):